News
Lilly's weight-loss medications Mounjaro and Zepbound are gaining market share on Novo's Wegovy and Ozempic, but investors ...
Orforglipron showed clinically meaningful results at 72 weeks, after three doses, in a pool of more than 3000 adults.
Some studies have linked the popular weight-loss drugs with a potentially higher risk of eye problems and vision loss. Should ...
Are weight loss shots like Ozempic and Wegovy safe long-term? It’s complicated. Some early studies suggest thyroid concerns ...
GLP-1 receptor agonists are associated with risk reductions for dozens of diseases and conditions in addition to rapid weight ...
A daily pill that works like Ozempic can help slimmers lose an average of two stone, trials have found. The study of ...
A chip addict who ballooned to 280 pounds scoffing down four bags a day managed to lose half her body weight naturally — ...
It looks likely we'll see oral GLP-1 drugs on the market by next year, with pharmaceutical company Eli Lilly reporting ...
Users of weight loss drugs such as Wegovy and Mounjaro, along with those who use type 2 diabetes drug Ozempic for weight loss ...
By taking 36 mg once per day - without food and water restrictions - participants lost an average of 12.4 percent of their body weight - about 27.3 pounds (12.4 kilograms). This was over the span of ...
Whatever your thoughts on weight-loss injections, their rise shows no signs of slowing. And now a Dubai restaurant has become ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results